Advanced search
Publication Cover
Experimental Lung Research Volume 28, 2002 - Issue 4
Submit an article Journal homepage
31
Views
11
CrossRef citations to date
0
Altmetric
Research Article

SUPPRESSIVE EFFECT OF PULMONARY HYPERTENSION AND LEUKOCYTE ACTIVATION BY INHALED PROSTAGLANDIN E 1 IN RATS WITH MONOCROTALINE-INDUCED PULMONARY HYPERTENSION

Shiro Kato Department of Cardiology and Pneumology, Dokkyo University School of Medicine, Tochigi Prefecture, Japan
,
Hiroyuki Sugimura Department of Cardiology and Pneumology, Dokkyo University School of Medicine, Tochigi Prefecture, Japan
,
Izumi Kishiro Department of Cardiology and Pneumology, Dokkyo University School of Medicine, Tochigi Prefecture, Japan
,
Masaru Machida Department of Cardiology and Pneumology, Dokkyo University School of Medicine, Tochigi Prefecture, Japan
,
Hidehiko Suzuki Department of Cardiology and Pneumology, Dokkyo University School of Medicine, Tochigi Prefecture, Japan
&
Noboru Kaneko Department of Cardiology and Pneumology, Dokkyo University School of Medicine, Tochigi Prefecture, Japan
Pages 265-273 | Published online: 02 Jul 2009

  • Jensen NK, Lundin S, Riksten SE: Vasodilation therapy after heart transplantation: effects of inhaled nitric oxide and intravenous prostacyclin, prostaglandin E1, and sodium nitroprusside. J Heart Lung Transplant. 1995;14:436-438.
  • McLean RF, Prielipp PC, Roenthal MH, Pearl RG: Vasodilator therapy in microembolic porcine pulmonary hypertension. Anesth Analg. 1990;71:35-41.
  • Bolliger C, Fourie P, Coetzee A: The effect of prostaglandin E1 on acute pulmonary artery hypertension during oleic acid-induced respiratory dysfunction. Chest 1991;99:1501-1506.
  • Fisher CA, Kappa JR, Sinha AK, Cothell ED, Reiser HJ, Addonzio VD: Comparison of equimolar concentrations of iloprost, prostacyclin, and prostaglandin E1 on human platelet-function. J Lab Clin Med. 1987;109:184-190.
  • Humbert M, Sanchez O, Fartouch M, Jagot J-L, Sitbon O, Simonneau G: Treatment of severe pulmonary hypertension secondary to connective tissue disease with continuous IV epoprostenol (prostacyclin). Chest. 1998;114:80-82.
  • Higenbottam TW, Butt AY, Dinh-Xaun AT, Takao M, Cremona G, Akamine S: Treatment of pulmonary hypertension with the continuous infusion of prostaglandin analogue, iloprost Heart 1998;79:175-179.
  • McLaughlin VV, Genthner DE, Panella MM, Hess DM, Rich S: Compassionate use of continuous prostacyclin in the management of secondary pulmonary hypertension: a case series. Ann Intern Med. 1994;130:740-743.
  • Walmrath D, Schermuty R, Pilch J, Grimminger F, Seeger W: Effect of inhaled versus intravenous vasodilators in experimental pulmonary hypertension. Eur Respir J. 1997;10:1084-1092.
  • Olschewski H, Walmrath D, Schermuty R, Ghofrani HA, Grimminger F, Seeger W: Aerosolized prostacyclin and iloprost in severe pulmonary hypertension. Ann Intern Med. 1996;124:820-824.
  • Walmrath D, Schneider T, Dilch J, Schermuty R, Grimminger F, Seeger W: Effects of aerosolized prostacyclin in severe pneumonia: impact of fibrosis. Am J Resp Crit Care Med. 1995;151:724-730.
  • Kato S, Ohnuma N, Ohno K, Takasaki K, Okamoto S, Asai T, Okuda M, Nakamoto T, Ezuka M: Change in sequestered leukocytes and platelets in the pulmonary microvasculature of rats with monocrotaline-induced pulmonary hypertension. Int J Microcirc. 1997;17:290-297.
  • Mitauchi T, Yorikane R, Sakai S, Sakurai T, Okada M, Nishikibe M, Yano M, Yamaguchi I, Sugishita Y, Goto K: Contribution of endogenous endothelin-1 to the progression of cardiopulmonary alterations in rats with monocrotaline-induced pulmonary hypertension. Circ Res. 1993;73:887-897.
  • Fulton RM, Hutchinson EC, Morgan JA: Ventricular weight in cardiac hypertrophy. Br Heart J. 1952; 14:413-420.
  • Vidgren M, Karkkainen A, Karjilainen P, Paronen P, Nuntinen J: Effect of powder inhaler design on drug deposition in the respiratory tract IntJ Pharm. 1988;42:211-216.
  • Pavia D, Thomson ML, Clarke SW, Shanon HS: Effect of different models of inhalation on drug delivery from a dry powder inhaler: a comparison with terbutaline sulphate in normal subjects. Eur Resp J. 1994;7:1839-1844.
  • Scott JP, Higeenbottam TW, Wallwark J: The acute effect of the synthetic prostacyclin analogue iloprost in primary pulmonary hypertension. Br J Clin Pharmacol 1990;6:231-234.
  • De Mala LJ, Gomez-Sanches MZ, Aranzana M: Long-term iloprost infusion therapy for severe pulmonary hypertension in patients with connective tissue disease. Arthritis Rhuem. 1994;37:15281533.
  • Sakuma F, Miyata M, Kasukawa R: Suppressive effect of prostaglandin EI on pulmonary hypertension induced by monocrotaline in rats. Lung. 1999;177:77-78.
  • Fartonkh M, Emilie D, Gall C, Monti G, Simonneau G, Humbert M: Chemokine macrophage inflammatory protein-1a mRNA expression in lung biopsy specimens of primary pulmonary hypertension. Chest 1998;114:509-518.
  • Wright L, Tuder RM, Wang J, Cool CD, Lepley RA, Voelkel NF: 5-Lipoxgenase activating protein (FLAP) immunoreactivity in lung from patients with primary pulmonary hypertension. Am J Respir Crit Care Med. 1998;157:219-229.
  • Tamura DY, Moore EE, Partrick DA, Johnson JL, Offner PJ, Sillman CC: Prostaglandin EI attenuates cytotoxic mechanisms of primed neutrophils. Shock. 1998;9:171-176.
  • Cirillo P, Golino P, Ragni M, Battaglia C, Pacifico F, Formisano S, Buno C, Condolleri M, Chiariello M: Activated platelets and leukocytes cooperatively stimulate smooth muscle cell proliferation and protooncogene expression via release of solible growth factors. Cardiovasc Res. 1999;43:210-218.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.